《大行報告》瑞信下調丘鈦科技(01478.HK)目標價至16元 評級「跑贏大市」
瑞信發表的研究報告指,丘鈦科技(01478.HK)5月份鏡頭模組出貨量為3,800萬台,按月跌11%,按年則升12%,今年以來鏡頭模組出貨量升25%至1.85億台,低於公司2021所指引的逾30%增長。
期內指紋模組出貨量為760萬組,按月跌24%,主要因為安卓需求減慢,而今年以來指紋模組出貨量按年增長36%至4,500萬組,高於公司對2021年的增長指引。
該行指出印度市場需求近期復甦,雖然仍未回復至原先水平,料新興市場需求復甦仍存在不確定性。該行將公司2021-23年盈利預測分別降5%、4%及3%,以反映鏡頭模組及平均銷售單價下降的影響,不過相關因素部分被指紋模組提升所抵銷,維持「跑贏大市」評級,目標價由17.7元降至16元,估計短期股價維持弱勢,但第三季出貨量改善或可再度帶動勢頭。(el/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.